Posts by: Iqra Mumal

News

MND Scotland has initiated a clinical trial to test the tolerability and effectiveness of interleukin-2 in the treatment of amyotrophic lateral sclerosis (ALS), also known as motor neurone disease ... Read more

June 22, 2018June 22, 2018

NINDS Gives $3.4M to Aquinnah to Advance ALS Therapies Targeting Stress Granules

News

The National Institute of Neurological Disorders and Stroke (NINDS) has awarded Aquinnah Pharmaceuticals $3.4 million to continue to develop and advance potential therapies to treat amyotrophic lateral sclerosis (ALS). ... Read more

June 21, 2018June 21, 2018

Online Forums Source of Empathy and Support for ALS and Other Patients, Study Says

News

Online health forums offers patients with chronic diseases a way to share experiences and develop connections with others in a similar situation — gaining access to a community that ... Read more

June 4, 2018June 4, 2018

Low Levels of Specific microRNA Linked to Nerve Cell Damage and ALS Progression in Early Study

News

Lower-than-usual levels of a molecule called miR126-5p — a type of microRNA, with a role in producing proteins — led to neuron degeneration and disease progression in a mouse ... Read more

May 23, 2018May 23, 2018

Voyager Shares Promising Pre-clinical Data About ALS Therapy Candidate VY-SOD101

News

Voyager Therapeutics presented new data from a study in an animal model of its clinical candidate VY-SOD101, showing the therapy is effective as it targets the most common cause ... Read more

May 10, 2018May 10, 2018

Biohaven Establishes Expanded Access Program for Investigational ALS Therapy BHV-0223

News

Biohaven Pharmaceuticals has established an expanded access program (EAP) for patients with amyotrophic lateral sclerosis (ALS) for its investigational treatment candidate, BHV-0223, the company recently announced. The United States Food ... Read more

May 1, 2018

New System Mimics Human Testing of Therapies for Neuromuscular Junction Diseases Like ALS

News

New technology that tests therapies designed for disorders of the neuromuscular junction, such as amyotrophic lateral sclerosis (ALS), closely mimics the human condition and offers a new method of ... Read more

April 9, 2018April 9, 2018

Lack of Enzyme Crimps Movement Nerve Cell Development, Study Suggests

News

Lack of an enzyme prevents movement nerve cells from developing properly, suggesting that the shortage may play a role in ALS, a Northwestern University study reports. The study in the ... Read more

March 16, 2018March 16, 2018

RNA-Protein Interaction Is Essential to Nerve Cell Communication, Study Finds

News

The interaction between an RNA molecule and a protein is essential for the growth of axons, the portion of movement nerve cells responsible for communicating with other nerve cells, a study ... Read more

March 14, 2018March 14, 2018

ALS-Linked Protein FUS Plays Major Role in Gene Expression, Study Finds

News

Scientists have discovered a key role for the ALS-linked protein known as fused in sarcoma (FUS) in a system that is crucial to regulating gene expression. The study, “FUS ... Read more

Posts by: Iqra Mumal

Iqra Mumal

MND Scotland Launches Clinical Trial to Assess Interleukin-2 in ALS Treatment

NINDS Gives $3.4M to Aquinnah to Advance ALS Therapies Targeting Stress Granules

Online Forums Source of Empathy and Support for ALS and Other Patients, Study Says

Low Levels of Specific microRNA Linked to Nerve Cell Damage and ALS Progression in Early Study

Voyager Shares Promising Pre-clinical Data About ALS Therapy Candidate VY-SOD101

Biohaven Establishes Expanded Access Program for Investigational ALS Therapy BHV-0223

New System Mimics Human Testing of Therapies for Neuromuscular Junction Diseases Like ALS

Lack of Enzyme Crimps Movement Nerve Cell Development, Study Suggests

RNA-Protein Interaction Is Essential to Nerve Cell Communication, Study Finds

ALS-Linked Protein FUS Plays Major Role in Gene Expression, Study Finds

Pin It on Pinterest